Potassium Citrate
- Product NDC
- 69452-194
- 11-digit product format
- 694520194
- Labeler code
- 69452
- Product ID
- 69452-194_b6453fd1-9688-357d-e053-2995a90a70c6
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Potassium Citrate
- Dosage form
- TABLET, EXTENDED RELEASE
- Route
- ORAL
- Labeler
- Bionpharma Inc.
- Application
- ANDA212799
- Marketing category
- ANDA
- Marketing start
- 2020-08-01
- Marketing end
- 0000-00-00
- Substance
- POTASSIUM CITRATE
- Active strength
- 15 meq/1
- Pharmacologic classes
- Acidifying Activity [MoA],Calculi Dissolution Agent [EPC],Anti-coagulant [EPC],Decreased Coagulation Factor Activity [PE],Calcium Chelating Activity [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2021-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 69452-194-20 | 69452019420 | 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (69452-194-20) | 2020-08-01 | 0000-00-00 | No | No | Current |
| 69452-194-30 | 69452019430 | 500 TABLET, EXTENDED RELEASE in 1 BOTTLE (69452-194-30) | 2020-08-01 | 0000-00-00 | No | No | Current |